Thakor AS, Giussani DA. Effects of acute acidemia on the fetal cardiovascular defense to acute hypoxemia. Am J Physiol Regul Integr Comp Physiol 295: R90 -R99, 2009. First published October 15, 2008 doi:10.1152/ajpregu.90689.2008.-In complicated pregnancy, fetal hypoxemia rarely occurs in isolation but is often accompanied by fetal acidemia. There is growing clinical concern about the combined effects of fetal hypoxemia and fetal acidemia on neonatal outcome. However, the effects on the fetal defense responses to acute hypoxemia during fetal acidemia are not well understood. This study tested the hypothesis that fetal acidemia affects the fetal defense responses to acute hypoxemia. The hypothesis was tested by investigating, in the late-gestation sheep fetus surgically prepared for long-term recording, the in vivo effects of acute fetal acidemia on 1) the fetal cardiovascular responses to acute hypoxemia and 2) the neural and endocrine mechanisms mediating these responses. Under general anesthesia, five sheep fetuses at 0.8 gestation were instrumented with catheters and Transonic flow probes around the femoral and umbilical arteries. After 5 days, animals were subjected to an acute hypoxemia protocol during intravenous infusion of saline or treatment with acidified saline. Treatment with acidified saline reduced fetal basal pH from 7.35 Ϯ 0.01 to 7.29 Ϯ 0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, ACTH, and cortisol. During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, ACTH, and cortisol. Acidemia also reversed the increase in umbilical vascular conductance during hypoxemia to vasoconstriction. In conclusion, the data support our hypothesis and show that acute acidemia markedly alters fetal hemodynamic, metabolic, and endocrine responses to acute hypoxemia.
ACTH; cortisol; catecholamines; umbilical vascular conductance; femoral vascular resistance ONE OF THE MOST COMMON CHALLENGES to the fetus during late gestation is an episode of O 2 deprivation. Acute hypoxemia, i.e., ϳ50% reduction of fetal arterial PO 2 (Pa O 2 ), elicits integrated cardiovascular, metabolic, and endocrine responses that facilitate fetal survival during the period of reduced O 2 availability (24, 43) . In late gestation, the fetal cardiovascular defense to acute hypoxemia is triggered via a carotid chemoreflex, resulting in transient bradycardia and redistribution of the cardiac output toward essential circulations, such as those perfusing the fetal brain, heart, and adrenal glands, at the expense of peripheral vascular beds. Once initiated, the peripheral vasoconstriction is maintained by the release of vasoactive agents into the fetal circulation (6, 7, 23, 24) . In addition, umbilical blood flow is maintained during acute hypoxemia or elevated when the severity of the hypoxemic challenge increases as a result of the combined effects of increased perfusion pressure and activity of nitric oxide across the umbilical vascular bed (48) . The metabolic response to acute hypoxemia involves increased circulating concentrations of glucose and lactate (27, 29) . The hyperglycemia during acute hypoxemia arises from the combined effects of reduced glucose consumption and increased glucose production by the fetus (27, 29) ; lactic acidemia results from the anaerobic metabolism of glucose in fetal peripheral tissues (9) . Acute hypoxemia can also activate the pituitary-adrenal and sympathoadrenomedullary axes, peripheral effector pathways of the stress system (11) . If the fall in basal Pa O 2 in the late-gestation fetus is greater than ϳ6 mmHg, activation of the pituitary-adrenal axis leads to increased release of ACTH from the anterior pituitary and glucocorticoids from the adrenal gland (2, 10) . Similarly, hypoxemia leading to activation of the sympathoadrenomedullary axis promotes secretion of catecholamines in the fetal circulation (46) . The increase in circulating catecholamine concentrations in the fetus contributes to the mechanisms mediating the peripheral vasoconstrictor (32) and glucogenic responses during hypoxemia (3) .
Although it is accepted that the late-gestation fetus can adapt successfully to acute hypoxemia, episodes of reduced fetal oxygenation in human pregnancy rarely occur in isolation; i.e., they are often accompanied by fetal acidemia (36) . Hence, there is a growing clinical concern about the effects of the combination of fetal hypoxemia and fetal acidemia compared with the effects of fetal hypoxemia alone on neonatal outcome (14, 17, 44, 47) . However, the effects on the fetal defense responses to acute hypoxemia during fetal acidemia are not well understood. The present study tested the hypothesis that fetal acidemia affects the fetal defense responses to acute hypoxemia. The hypothesis was tested by investigating, in the late-gestation sheep fetus surgically prepared for long-term recording, the in vivo effects of acute fetal acidosis on 1) the fetal cardiovascular responses to acute hypoxemia and 2) the neural and endocrine mechanisms mediating these responses. The effects of fetal acidemia on the fetal hemodynamic responses to acute hypoxemia concentrated on essential and peripheral vascular beds via continuous measurement of umbilical and femoral blood flow, respectively, via perivascular Transonic flow probes.
MATERIALS AND METHODS

Surgical Preparation
All procedures were performed under the United Kingdom Animals (Scientific Procedures) Act 1986 and were approved by the Ethical Review Committee of the University of Cambridge. Five Welsh Mountain sheep fetuses were surgically instrumented for longterm recording at 125 Ϯ 1 days of gestation (full term ϳ145 days) using strict aseptic conditions (22) . Food, but not water, was withheld from the pregnant ewes for 24 h before surgery. After induction with thiopentone sodium (20 mg/kg iv; Intraval Sodium, Merial Animal Health, Rhone Mérieux, Dublin, Ireland), general anesthesia (1.5-2.0% halothane in 50:50 O 2-N2O) was maintained using positivepressure ventilation. Midline abdominal and uterine incisions were made, the fetal hindlimbs were exteriorized, and, on one side, femoral arterial (0.86 mm ID, 1.52 mm OD) and venous (0.56 mm ID, 0.96 mm OD) catheters (Critchly Electrical Products, NSW, Australia) were inserted. The catheter tips were advanced to the descending aorta and inferior vena cava, respectively. Another catheter was anchored onto the fetal hindlimb for recording of the reference amniotic pressure. Transonic flow transducers were also positioned around the contralateral femoral artery (2R or 3S) and around one of the umbilical arteries, inside the fetal abdomen, close to the common umbilical artery (4SB). The uterine incisions were closed in layers, the dead space of the catheters was filled with heparinized saline (80 IU heparin/ml in 0.9% NaCl), and the catheter ends were plugged with sterile brass pins. The catheters were then exteriorized via a keyhole incision in the maternal flank and kept inside a plastic pouch sewn onto the maternal skin.
Postoperative Care
During recovery, ewes were housed in individual pens in rooms with a 12:12-h light-dark cycle; they had free access to hay and water and were fed concentrates twice daily (100 g of sheep nuts no. 6, H & C Beart, Kings Lynn, UK). Antibiotics were administered daily: penicillin G procaine (0.20 -0.25 mg/kg, Depocillin; Mycofarm, Cambridge, UK) intramuscularly to the ewe and ampicillin intravenously to the fetus and into the amniotic cavity (150 mg/kg, Penbritin; SmithKline Beecham Animal Health, Hertfordshire, UK). The ewes also received 2 days of postoperative analgesia with phenylbutazone (10 -20 mg/kg po; Equipalazone paste, Arnolds Veterinary Products, Shropshire, UK). Generally, normal feeding patterns were restored within 48 h of recovery. After 72 h of postoperative recovery, ewes were transferred to metabolic crates, where they were housed for the remainder of the protocol. The arterial, venous, and amniotic catheters were connected to sterile pressure transducers (COBE, Argon Division, Maxim Medical, Athens, TX), and calibrated mean fetal arterial blood pressure (corrected for amniotic pressure) and fetal heart rate (triggered via a tachometer from the pulsatility in the arterial blood pressure signal) were recorded continually using a computerized data acquisition system (Department of Physiology, Cambridge University, UK). While the animals were in the metabolic crates, the patency of the fetal catheters was maintained by a slow continuous infusion of heparinized saline (80 IU heparin/ml at 0.1 ml/h in 0.9% NaCl) containing antibiotic (1 mg/ml benzylpenicillin; Crystapen, ScheringPlough, Animal Health Division, Welwyn Garden City, UK).
Experimental Protocol
After Ն5 days of postoperative recovery, all fetuses were subjected to two experimental protocols that were carried out on consecutive days in a randomized order (Fig. 1) . Each protocol consisted of a 3-h period consisting of 1.5 h of normoxia, 0.5 h of hypoxemia, and 1 h of recovery, during a slow intravenous infusion of heparinized saline vehicle (80 IU heparin/ml in 0.9% NaCl) or treatment with heparinized saline acidified with HCl (pH 0.9, 0.3 Ϯ 0.1 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 iv) with infusion rates titrated to achieve a reduction in fetal arterial pH (pH a) to ϳ7.29. The doses of HCl were calculated retrospectively from the fetal weights (2.9 Ϯ 0.2 kg) obtained postmortem. All treatments started 1 h before the onset of hypoxemia and ran continuously through the hypoxemic challenge and 15 min into recovery (Fig. 1) . Acute hypoxemia in the fetus was induced by maternal inhalational hypoxia. Briefly, a large transparent respiratory hood was placed over the ewe's head, and air was passed into the hood at a rate of ϳ50 l/min for the 1.5-h period of normoxia. After this control period, acute fetal hypoxemia was induced for 30 min by changing the concentrations of gases breathed by the ewe to 6% O 2 in N2 with small amounts of CO2 (15 l/min air, 35 l/min N2, and 1.5-2.5 l/min CO 2). This mixture was designed to reduce fetal PaO 2 to ϳ10 mmHg and maintain arterial PCO2 (PaCO 2 ). After 0.5 h of hypoxemia, the ewe was returned to breathing air for the 1-h recovery period. At the end of the experimental protocol, the ewes and fetuses were euthanized with a lethal dose of pentobarbitone sodium (200 mg/kg iv; Pentoject, Animal Ltd, York, UK). Autopsy was carried out at 128 Ϯ 1 days of gestation. Each fetus was weighed, and the positions of the implanted catheters and the flow probes were confirmed.
In pilot experiments, acidified saline was infused at different concentrations, infusion rates, and durations to obtain the most suitable infusion regimen to achieve a reduction in basal fetal pH a to the required mean value. An infusion of acidified (pH 0.9) saline at a rate of 0.3 Ϯ 0.1 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 led to a decrement from baseline in fetal pHa of ϳ0.07 and persistently maintained the pH at this level for up to 3 h. During these pilot experiments, there was no change in any of the hemodynamic variables measured in the fetus or in fetal blood gases during 3 h of acid infusion under baseline conditions.
Blood Sampling Regimen
During the acute hypoxemia protocol, descending aortic blood samples (0.3 ml) were taken using sterile techniques from the fetus at set time intervals to determine arterial blood gas and metabolic status (Fig. 1) . Arterial blood gas and acid-base measurements were determined using a blood gas analyzer (model ABL5, Radiometer, Copenhagen, Denmark; measurements corrected to 39.5°C), percent saturation of Hb with O 2 (Sat Hb) and blood Hb concentration ([Hb]) were determined using a hemoximeter (model OSM3, Radiometer), and blood glucose and lactate concentrations were measured by an automated analyzer (2300 Stat Plus Glucose/Lactate Analyser, Yellow Springs Instrument, Farnborough, UK). An additional 4 ml of arterial blood were withdrawn at set intervals for hormone analyses (Fig. 1) . The samples were collected under sterile conditions into chilled , n ϭ 5). Arrows represent times at which arterial blood samples were collected; dashed arrows indicate 2 extra samples for blood gases.
heparin tubes (2 ml Li ϩ /heparin tubes; LIP, Shipley, West Yorkshire, UK) containing reduced glutathione (4 nmol per tube; catalog no. G-4251, Sigma Chemical) and EGTA (5 nmol per tube; catalog no. E-4378, Sigma Chemical) for catecholamine (epinephrine and norepinephrine) analysis or into chilled EDTA tubes (2 ml K ϩ /EDTA; LIP) for ACTH and cortisol analysis. All samples were centrifuged at 4,000 rpm for 4 min at 4°C. The plasma was dispensed into prelabeled tubes, and the samples were stored at Ϫ80°C until analysis. All hormone measurements were performed within 2 mo of sample collection.
Hormone Analyses
Catecholamine assay. Fetal plasma epinephrine and norepinephrine concentrations were measured by HPLC using electrochemical detection, as previously described in detail (18) . The samples were prepared by absorption of 250 l of plasma onto acid-washed alumina, and 20-l aliquots of the 100-l perchloric acid elutes were injected onto the column. Dihydroxybenzylamine was added as the internal standard to each plasma sample before absorption. The limit of sensitivity for the assay was 20 pg/ml for epinephrine and norepinephrine. Recovery ranged from 63% to 97%, and all catecholamine values were corrected for their respective recovery. The interassay coefficients of variation (CV) for epinephrine and norepinephrine were 7.3% and 6.2%.
ACTH assay. Fetal plasma ACTH concentrations were measured using a commercially available double-antibody 125 I-RIA kit (DiaSorin, Stillwater, MN), as previously described (42) . The kit contained a set of ACTH standards (porcine; range 20 -500 pg/ml), ACTH quality control samples, lyophilized rabbit anti-ACTH antiserum, 125 I-labeled synthetic ACTH, and a second antibody-precipitating complex (goat anti-rabbit ␥-globulin serum and polyethylene glycol in buffer). Reagents were reconstituted in deionized water and kept on crushed ice. Duplicate 100-l aliquots of the ACTH standards, quality controls, and unknown plasma samples (taken from previously unthawed K ϩ /EDTA-treated plasma aliquots) were incubated overnight at 5°C with 200 l of anti-ACTH antiserum and 200 l of 125 I-labeled ACTH. Bound and free ACTH fractions were separated by immunoprecipitation with the second antibody-precipitating complex (500 l). After centrifugation (3,600 rpm for 20 min at 20 -25°C), the supernatant was rapidly decanted and discarded, and the residue pellets were allowed to dry. A gamma scintillation counter (Cobra II Auto-Gamma, Packard Bioscience, Pangbourne, Berks, UK) was used to count the radioactivity of each pellet for 2 min, together with that of duplicate nonspecific binding samples (anti-ACTH antiserum omitted) and that of total-counts tubes (200 l of 125 I-labeled ACTH). A standard curve was produced by the computer using a logistic curve fit, and ACTH concentrations were calculated for each pellet.
The lower limit of detection of the assay (90% bound/free) was 10 -25 pg/ml. The intra-assay CV for three plasma pools (mean concentration ϭ 69, 281, and 600 pg/ml) were 12.5, 6.3, and 8.1%, respectively. The interassay CV for two plasma pools (mean concentration ϭ 36 and 136 pg/ml) were 6.0 and 6.7%, respectively. The anti-ACTH antiserum showed Ͻ0.01% cross-reactivity against ␣-melanocyte-stimulating hormone, ␤-endorphin, ␤-lipotropin, leucine enkephalin, methionine enkephalin, bombesin, calcitonin, parathyroid hormone, follicle-stimulating hormone, AVP, oxytocin, and substance P.
Cortisol assay. Fetal plasma cortisol concentrations were measured by RIA using [ 3 H]cortisol as tracer, as previously described (20) . Duplicate 20-l plasma samples were taken from previously unthawed K ϩ /EDTA-treated sample aliquots and extracted twice in 300 l of ethanol. After each extraction, the aliquots were centrifuged and the ethanol layer was decanted into a bacteriological test tube. The combined ethanol extracts were evaporated in a drier (Speedvac Concentrator, SVC 200H, Stratech Scientific, Luton, UK) overnight. Residues were reconstituted in 100 l of PBS (pH 7.0) and allowed to stand at 5°C for Ն2 h. Samples in which cortisol concentration values were predicted to be in the upper range of the standard curve were diluted using PBS to reduce the concentration to within the most sensitive range (1-10 ng/ml) of the standard curve. Values for these samples were subsequently corrected for the dilution factor used in each case. The plasma extracts, quality control samples, and working standards (1, 2.5, 5, 10, 25, 50, and 100 ng/ml) were incubated overnight (5°C) with 100 l of antiserum (Tenovus Institute, Cardiff, UK) and 100 l of [1,2,6,7- 3 H]cortisol (TRK407, Amersham Pharmacia Biotech UK, Little Chalfont, Bucks, UK). Bound and free cortisol fractions were separated using stirred dextran-coated charcoal suspension (300 l, 0.075 g% dextran and 0.75 g% activated charcoal in PBS). After immediate centrifugation (3,600 rpm for 7 min at 4°C), the supernatant was rapidly decanted into scintillation vial inserts, and 4 ml of scintillant (OptiPhase HiSafe, Fisons Chemicals, Loughborough, UK) were added to each insert. The inserts were capped, and the contents were thoroughly mixed. After a 1-h equilibration period, a scintillation counter (1216 RackBeta Liquid Scintillation Counter, LKB Wallac) was used to count the radioactivity of each insert for 5 min, including the radioactive content of duplicate nonspecific binding samples (antiserum omitted) and total-counts tubes (100 l of [ 3 H]cortisol). Recoveries averaged 90%. A standard curve was produced by the computer using a spline curve fit, and cortisol concentrations were calculated for each sample.
The lower limit of detection of the assay was 1.0 -1.5 ng/ml. The intra-assay CV was 5.3% for a mean value of 13 ng/ml. The interassay CV for two plasma pools (mean concentration ϭ 13 and 28 ng/ml) were 13.6 and 11.4%, respectively. The cross-reactivities of the antiserum at 50% binding with other cortisol-related compounds were 0.5% for cortisone, 2.3% for corticosterone, 0.3% for progesterone, and 4.6% for deoxycortisol.
Data and Statistical Analyses
Values are means Ϯ SE. Fetal arterial blood pressure, heart rate, femoral blood flow, femoral vascular resistance (FVR), umbilical blood flow, and umbilical vascular conductance were recorded continually at 1-s intervals using the computerized data acquisition system. The concentration of protons ( (21) .
For the acute hypoxemia experiment, values for all arterial blood gas and metabolic variables are expressed at 0 (N0) and 75 (N75) min of normoxia, 5 (H5), 15 (H15), and 30 (H30) min of hypoxemia, and 30 (R30) and 60 (R60) min of recovery. Values for all endocrine variables are expressed at 0 (N0) and 75 (N75) min of normoxia, 15 (H15) and 30 (H30) min of hypoxemia, and 60 (R60) min of recovery. Summary measure analysis was applied to the serial cardiovascular data to focus the number of comparisons (34) . The area under the curve was calculated at 30-min intervals (N1, N2, N3, H, R1, R2) for the absolute data and for the change from mean normoxic baseline data describing the hemodynamic responses. All measured variables were assessed statistically using a two-way ANOVA with repeated measures comparing the effect of time and treatment and interactions between time and treatment. Functional chemoreflex analysis was performed to assess the effects of acidemia on fetal cardiac and vasomotor chemoreflex responses. For this analysis, linear regression lines were plotted for the cardiovascular chemoreflex response of each fetus, and a comparison between the slopes was conducted according to Armitage and Berry (4) . The relationship between parallel measurements of plasma concentrations of ACTH and cortisol in all individual fetuses was assessed using the Pearson product moment correlation coefficient test. The mean change in adrenocortical respon-siveness to ACTH (gradient and intercept of the cortisol-ACTH relationship) was assessed statistically using Student's t-test for paired data.
Where a significant effect of time or treatment was indicated using an ANOVA with repeated measures, Tukey's post hoc test was used to isolate the statistical differences. For all comparisons, statistical significance was accepted when P Ͻ 0.05.
RESULTS
Fetal Arterial Blood Gas and Metabolic Status
Basal values for fetal arterial blood gas status and fetal concentrations of blood glucose and lactate were similar in all fetuses and were within the normal range for the Welsh Mountain sheep fetus at ϳ125 days gestation (Table 1, Fig. 2 ). Infusion with saline had no effect on basal arterial blood gas or metabolic status, but it produced a significant decrease in fetal pH a with a corresponding increase in [ Fig. 2 ).
Fetal Cardiovascular Responses to Acute Hypoxemia
Basal values for fetal arterial blood pressure, heart rate, femoral blood flow, and FVR were similar in all fetuses (Fig. 3) . Infusion with saline or treatment with acidified saline had no effect on basal cardiovascular function (Fig. 3) . Acute hypoxemia during saline infusion induced significant increments in fetal arterial blood pressure (8.8 Ϯ 0.8 mmHg) and FVR (4.32 Ϯ 0.91 mmHg⅐ml Ϫ1 ⅐min) and significant falls in fetal heart rate (Ϫ20 Ϯ 3 beats/min) and femoral blood flow (Ϫ26 Ϯ 3 ml/min; Fig. 3 ). Treatment with acidified saline had no effect on the pressor increment during acute hypoxemia (9.3 Ϯ 2.1 mmHg); however, it significantly enhanced the magnitude of the changes from baseline in the femoral vasoconstrictor (10.68 Ϯ 1.60 mmHg⅐ml Ϫ1 ⅐min) and bradycardic (Ϫ57 Ϯ 10 beats/min) responses to acute hypoxemia (Fig. 3) . Interestingly, there was a rebound hypertensive response in all fetuses treated with acidified saline during the first 15 min of recovery following the hypoxemic challenge (P Ͻ 0.05; Fig.  3 ). During recovery, all cardiovascular variables returned toward basal values in saline-infused controls. In contrast, in fetuses treated with acidified saline, all cardiovascular variables remained significantly elevated above or reduced below both basal and control values by the end of the experimental protocol (Fig. 3) .
Basal values for umbilical blood flow and umbilical vascular conductance were similar in all fetuses: in saline-treated fetuses, umbilical blood flow was 196 Ϯ 29 ml/min and umbilical vascular conductance was 4.02 Ϯ 0.46 ml⅐min Ϫ1 ⅐mmHg
Ϫ1
; in . Acute hypoxemia during saline infusion induced significant increments in fetal arterial blood pressure, umbilical blood flow (43 Ϯ 9 ml/min), and umbilical vascular conductance (0.15 Ϯ 0.22 ml⅐min Ϫ1 ⅐mmHg Ϫ1 ; Fig. 4) . In marked contrast, treatment with acidified saline not only abolished the umbilical vasodilator response to acute hypoxemia, but it resulted in a significant decrement from baseline in umbilical vascular conductance during the challenge (Ϫ0.97 Ϯ 0.28 ml⅐ min Ϫ1 ⅐mmHg Ϫ1 ; Fig. 4 ). During recovery, umbilical blood flow and vascular conductance remained significantly elevated above basal values in salineinfused fetuses but returned toward basal values by the end of the experimental protocol in fetuses treated with acidified saline (Fig. 4) .
Functional Chemoreflex
Acute hypoxemia reduced fetal Pa O 2 to a similar level in all fetuses during infusion with saline or acidified saline (Table 1) . Within the first 15 min of the onset of acute hypoxemia, the fall in Pa O 2 was associated with a significant reduction in fetal heart rate and a significant increase in FVR in both groups. However, the nadir for fetal heart rate and the maximum increase in FVR during the first 15 min of hypoxemia were greater when fetuses were treated with acidified saline (Ϫ75 Ϯ 7 beats/min and 12.48 Ϯ 1.39 mmHg⅐ml Ϫ1 ⅐min) than when they were infused with normal saline (Ϫ35 Ϯ 7 beats/min and 3.97 Ϯ 0.99 mmHg⅐ml Ϫ1 ⅐min). Consequently, when individual values for heart rate and FVR were plotted against corresponding values for Pa O 2 during normoxia and the first 15 min of acute hypoxemia (data not shown), the slopes for all individual data points representing the cardiac (Ϫ7.0ϫ vs. Ϫ2.8x) and femoral vasoconstrictor (1.2x vs. 0.3x) chemoreflex function were greater in fetuses during treatment with acidified saline than during infusion of normal saline (P Ͻ 0.05).
Fetal Endocrine Responses to Acute Hypoxemia
Basal values for fetal plasma concentrations of epinephrine, norepinephrine, ACTH, and cortisol were similar in all fetuses (Figs. 5 and 6 ). Infusion with saline or treatment with acidified saline had no effect on basal catecholamine concentrations or basal pituitary-adrenocortical function (Figs. 5 and 6 ). Acute hypoxemia during saline infusion induced significant increments from baseline in plasma concentrations of epinephrine (414 Ϯ 89 pg/ml), norepinephrine (2,665 Ϯ 353 pg/ml), ACTH (303 Ϯ 70 pg/ml), and cortisol (11 Ϯ 6 ng/ml; Figs. 5 and 6). Treatment with acidified saline resulted in a marked enhancement in the plasma epinephrine (10,412 Ϯ 5,541 pg/ml), norepinephrine (9,474 Ϯ 3,689 pg/ml), ACTH (572 Ϯ 154 pg/ml), and cortisol (37 Ϯ 2 ng/ml) responses to acute hypoxemia (Figs. 5 and 6 ). During recovery, plasma concentrations of all hormones returned toward basal values in all fetuses (Figs. 5 and 6 ).
Correlation analysis of paired plasma ACTH and cortisol values for all individual fetuses under basal and hypoxemic conditions during saline infusion (r ϭ 0.62, n ϭ 20, P Ͻ 0.01) or treatment with acidified saline (r ϭ 0.79, n ϭ 20, P Ͻ 0.01) revealed significant linear relationships (Fig. 7) . Treatment with acidified saline did not affect the intercept or the slope of the steroid-peptide relationship compared with saline infusion ( Fig. 7 ; P Ͼ 0.05), thereby suggesting no change in the set point or the sensitivity of the adrenal cortex to ACTH stimulation.
DISCUSSION
This study tested the hypothesis that fetal acidemia affects the fetal defense responses to acute hypoxemia by investigating the in vivo effects of acute fetal acidemia on the fetal cardiovascular, metabolic, and endocrine responses to acute hypoxemia in the late-gestation ovine fetus. The data support the hypothesis tested and show that acute acidemia had no effect on basal cardiovascular, metabolic, or endocrine function but markedly enhanced the bradycardia, femoral vasoconstriction, and metabolic and endocrine responses to acute hypoxemia in the fetus. In marked contrast, acute acidemia not only prevented the dilator response of the umbilical vascular bed to acute hypoxemia, but it also reversed the response to constriction. Greater carotid chemoreflex function and an enhanced increase in plasma catecholamines may contribute to the physiological mechanisms underlying the altered cardiovascular and metabolic responses to acute hypoxemia in acutely acidemic fetuses.
The fetal bradycardia and peripheral constrictor response to acute hypoxemia are established carotid chemoreflexes, since bilateral section of the carotid sinus nerves abolishes the reduction in heart rate and the initial increase in FVR during acute hypoxemia (5, 25). As the hypoxemic episode continues, catecholamines are released into the fetal circulation and act to maintain the peripheral vasoconstriction (30, 32) . The origin of the increase in epinephrine and norepinephrine in fetal plasma during acute hypoxemia has been shown to be primarily from the fetal adrenal gland, inasmuch as adrenal demedullation completely abolished the rise in plasma epinephrine concentration and reduced the norepinephrine response to 10% of normal (31) . Since a large component of the increase in total Fig. 3 . Fetal cardiovascular responses to acute hypoxemia. A: arterial blood pressure, heart rate, femoral blood flow, and femoral vascular resistance calculated every minute during 1.5 h of normoxia, 0.5 h of hypoxemia (within vertical dashed lines), and 1 h of recovery for fetuses during saline infusion (n ϭ 5) or treatment with acidified (pH 0.9) saline (0.
, n ϭ 5). B: statistical summary of cardiovascular responses shown as area under the curve every 30 min during normoxia, hypoxemia, and recovery for fetuses during saline infusion (E) or treatment with acidified (pH 0.9) saline (F; 0.
). Values are means Ϯ SE (n ϭ 5).
a P Ͻ 0.05 vs. N1; b P Ͻ 0.05 vs. saline infusion (2-way repeated-measures ANOVA with Tukey's post hoc test). catecholamine output from the fetal adrenal gland during acute hypoxemia is mediated via activation of the splanchnic nerves (31), elevations in plasma concentrations of epinephrine and norepinephrine in the fetal sheep circulation are good indexes of increased sympathetic outflow during stimulated conditions.
Data in the present study show that acute acidemia enhanced the bradycardic and femoral vasoconstrictor response to hypoxemia, possibly by sensitizing the carotid chemoreflex. During hypoxemia, the glomus cells of the carotid body become uncoupled, leading to a decrease in their junctional conductance, which results in the release of transmitters toward the carotid sinus nerve sensory terminals (15) . The junctional channel proteins between glomus cells are directly regulated by pH, with acidemia shown to increase their uncoupling (1). Hence, acute acidemia could sensitize the fetal carotid body, thereby promoting a greater increase in autonomic outflow for any given fall in Pa O 2 . The enhanced bradycardic response to acute hypoxemia supports this notion, suggesting a greater vagal outflow in acidemic fetuses. Evidence of an enhanced increase in sympathetic outflow during acute hypoxemia in acidemic fetuses is derived from the marked augmentation of the plasma epinephrine and norepinephrine responses to acute hypoxemia. Similarly, Lewis and Sadeghi (33) demonstrated that acidemia significantly potentiated the magnitude of the plasma catecholamine response to acute hypoxemia in the ovine fetus in response to splanchnic nerve stimulation. In vitro studies using the rat adrenal medulla showed that acidemia can directly stimulate catecholamine secretion, in isolation (19) or as an additive effect with hypoxemia (41). The enhanced plasma catecholamine response to acute hypoxemia in acidemic fetuses may also act to maintain the greater overall peripheral vasoconstrictor response.
In marked contrast to the effects on the peripheral circulation, further data reported in the present study show that acute acidemia reversed the umbilical hemodynamic response to hypoxemia from dilatation to constriction. In a previous investigation of the effects of acute acidemia on basal cardiovascular and endocrine function in the ovine fetus, Wood and Chen (49) reported that infusion of acid into the fetal circulation increased fetal Pa CO 2 . In the adult animal with spontaneous ventilation, arterial acidemia increases ventilation via reflex mechanisms, correcting any increase in Pa CO 2 . However, in the fetus, gas exchange is controlled by alterations in umbilical-placental blood flow. Wood and Chen, therefore, concluded that the increase in fetal Pa CO 2 following acute acidemia in their study may represent failure of the umbilicoplacental vascular bed to increase flow to buffer this effect, but they did not measure umbilical blood flow. The results of our study support this prediction and confirm that umbilical vascular conductance not only fails to increase, but it actually decreases, during acute acidemia. The reduction of fetal pH a reported in the present study (an average of Ϫ0.05) was significantly less than that reported previously (Ϫ0.4) (49) . The comparatively milder acidemia may not only explain the lack of an increase in fetal Pa CO 2 in the present study during basal conditions, but it also highlights how sensitive the umbilical vascular bed may be to increases in fetal catecholamine levels, outweighing any vasodilator effects during stressful conditions. Several studies have shown that the umbilical vasculature does constrict in response to adrenergic receptor stimulation (8, 53) . Taken together, past and present evidence, therefore, suggests that fetuses compromised by acidemia may be at greater risk during acute hypoxemic episodes, whereby augmented stimulated plasma catecholamine responses in the fetus may compromise umbilicoplacental perfusion, triggering a vicious cycle.
Interestingly, although acute acidemia had no effect on the magnitude of the arterial blood pressure response to acute hypoxemia, there was a "rebound" hypertension at the beginning of the recovery period. During hypoxemia, the effects of increasing plasma catecholamine levels on the fetal heart are opposed by increased vagal discharge. The sudden increase in fetal arterial blood pressure during recovery in acidemic fetuses may result from the augmented catecholamine drive, in the absence of any vagal outflow, on fetal heart rate and cardiac output. Greater circulating levels of catecholamines will also require a longer duration for their metabolic disposition, thereby prolonging the duration of their effects, as demonstrated by the maintained elevation of fetal arterial blood pressure and femoral vasoconstriction throughout recovery in the acidemic fetus.
It is well established that activation of the sympathetic nervous system and an increase in circulating concentration of catecholamines are responsible for the fetal glycemic response to acute hypoxemia (3, 28) . Data from the present study support this theory and show that although acute fetal acidemia had no effect on basal metabolic function and basal plasma catecholamine concentrations, it enhanced the glycemic and catecholaminergic responses to acute hypoxemia in the lategestation fetus. However, since acidemia has been shown to also enhance glucose-stimulated insulin release (39), the overall effect of acidemia on fetal circulating glucose concentrations is likely to be partially offset by increased insulin release. In contrast to the glycemic response, acute fetal acidemia did not significantly affect the lactic acidemic response to acute hypoxemia, despite the elevated fetal peripheral vasoconstrictor response. This may be attributed to acidemia-enhanced uptake of lactate by various organs, as has been shown for the liver (45) . In addition, the placenta can act as a major site of lactate clearance from the fetal circulation, especially during periods of adverse intrauterine conditions (26) . This effect may be enhanced by acidemia, inasmuch as the reduction in umbilical arterial perfusion would slow the transit time of circulating lactate through the umbilicoplacental vascular bed, thereby favoring placental lactate uptake.
Previous studies have shown that acute acidemia in the late-gestation fetus stimulates the hypothalamus-pituitaryadrenal (HPA) axis under basal conditions, resulting in an increase in ACTH release from the pituitary and an increase in cortisol release from the adrenal cortex (49, 51) . In contrast, results from the present study show that acute fetal acidemia had no effect on basal concentrations of plasma ACTH and cortisol. This difference may again be due to failure to attain the threshold of acidemia required to stimulate ACTH and cortisol secretion, since the degree of acidemia induced in fetuses in the present study was significantly less than that reported previously (49, 51) . During acute hypoxemia, fetal acidemia markedly increased the magnitude of the plasma ACTH and cortisol responses, but it had no effect on the intercept or the slope of the steroid-peptide relationship, thereby demonstrating that there was no change in the set point or sensitivity of the adrenal cortical response to ACTH. This in agreement with previous studies that reported no effect of acidemia on ACTH-stimulated cortisol secretion (38) . The sensitizing effects of acute acidemia on the fetal HPA axis may therefore be at the level of the hypothalamus and/or the pituitary. At the level of the hypothalamus, acidemia may increase the release of corticotropin-releasing hormone (CRH) and/or AVP, since both hormones have been shown to stimulate the release of ACTH from the fetal anterior pituitary (16, 52) . Although there is no available evidence for an effect of acidemia on the release of hypothalamic CRH, Wood and Chen (49) reported that acidemia directly stimulates the release of AVP in fetal sheep, whereas Gardner and colleagues (20) showed a markedly enhanced AVP response to acute hypoxemia in spontaneously acidemic fetuses. Furthermore, since catecholaminergic neurons in the hypothalamus have been shown to be functional in the sheep fetus during late gestation under conditions of acute hypoxemic stress (35) , it is possible that acidemia could increase the release of CRH from hypothalamic neurons by enhancing sympathetic activity (33) . At the level of the pituitary, acidemia can directly stimulate the secretion of ACTH in the sheep fetus (51), but whether this is a direct effect on pituitary corticotroph cells or occurs higher up the axis remains unknown, and the mechanism mediating this effect in the adult appears different from that in the fetus. For instance, in the adult, but not the fetus, acidemia stimulates the release of ACTH via thromboxane (12, 13, 50) .
Perspectives and Significance
The data in the present study show that acute acidemia markedly affects the fetal hemodynamic, metabolic, and endocrine responses to an episode of acute hypoxemia in the late-gestation ovine fetus. Components of these findings are of clinical relevance. For instance, spinal anesthesia is widely used in clinical practice, inasmuch as it is commonly considered to be more practical and safer than other techniques for the mother and unborn child (37) . A recent meta-analysis concluded that spinal anesthesia induces fetal metabolic acidosis, an effect that is exacerbated by ephedrine when used to manage maternal blood pressure (40) . Although acidemia enhances the fetal cardiovascular, metabolic, and endocrine defense to acute hypoxemic stress, the data in the present study show that acidemia and increased concentrations of catecholamines are associated with important constrictor effects on the umbilicoplacental circulations, particularly during fetal distress. These findings should be considered when planning the management of maternal anesthesia and when assessing cardiovascular indexes of fetal health, for instance, via Doppler blood flow velocimetry or fetal heart rate monitoring, in pregnancies with suspected fetal hypoxia and acidemia.
